Paclitaxel

13 registered clinical trials studyying Paclitaxel — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons NCT07231835	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Not Yet Recruiting	Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head an NCT05835804	Centre Hospitalier Universitaire, Amiens	Phase 2
Recruiting	Effect of Alpha Lipoic Acid on Chemotherapy Induced Neurological Changes in Breast Cancer Patients NCT06406127	Ain Shams University	Phase 4
Unknown	A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin NCT05620654	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 1
Recruiting	Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian NCT04921527	Chipscreen Biosciences, Ltd.	Phase 3
Unknown	Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis NCT04943653	Seoul St. Mary's Hospital	Phase 1 / Phase 2
Recruiting	European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Fem NCT04743180	iVascular S.L.U.	—
Recruiting	Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer NCT06490159	City of Hope Medical Center	—
Completed	Predicting the Efficacy in Advanced Gastric Cancer. NCT06490055	City of Hope Medical Center	—
Completed	Drug Eluting Balloon Angioplasty Versus Nitinol Stent Implantation in the Superficial Femoral Artery NCT02212470	Instituto Dante Pazzanese de Cardiologia	Phase 4
Unknown	Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer NCT01848197	Taizhou Hospital	N/A
Completed	Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclita NCT00516724	AstraZeneca	Phase 1
Completed	CCRT for Esophageal Cancer. NCT02607982	Hangzhou Cancer Hospital	Phase 2